Pictet Asset Management
NUVB icon

Pictet Asset Management’s Nuvation Bio NUVB Stock Holding History

Pictet Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176K Hold
40,984
– – ﹤0.01% 1962
2025
Q4 		$367K Buy
40,984
+20,585
+101% +$128K ﹤0.01% 1603
2025
Q3 		$75.5K Sell
20,399
-26,786
-57% -$73K ﹤0.01% 2006
2025
Q2 		$92K Hold
47,185
– – ﹤0.01% 1952
2025
Q1 		$83K Buy
47,185
+13,514
+40% +$30.8K ﹤0.01% 1957
2024
Q4 		$89.6K Buy
+33,671
New +$86.7K ﹤0.01% 1991
2024
Q3 		– Sell
-17,124
Closed -$50K – 2036
2024
Q2 		$50K Buy
+17,124
New +$52.3K ﹤0.01% 1947

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pictet Asset Management's NUVB Position: Q1 2026 in Review

Pictet Asset Management held its Nuvation Bio (NUVB) position steady in Q1 2026 at 40,984 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Pictet Asset Management first reported a position in NUVB in Q2 2024 and has held it in 7 quarters since. The position peaked at $367K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Pictet Asset Management held 40,984 shares of Nuvation Bio worth $176K as of Q1 2026.
  • Pictet Asset Management left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1962 holding.
  • Pictet Asset Management first reported a position in Nuvation Bio in Q2 2024 and has held it in 7 quarters since.
  • Pictet Asset Management's Nuvation Bio position peaked at $367K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.